SEARCH RESULTS FOR: "Tag: GBT"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(1)
2018(2)
2017(2)
2016(1)
CATEGORIES
Analyst Update(2)
Buzz Stocks(2)
Intraday Option Activity(2)
Stocks On the Move(2)

6/14/2019 2:37 PM
Global Blood Therapeutics Inc (NASDAQ:GBT) stock is down 10.1% to trade at $51.70, after the California-based biopharmaceutical firm presented data for its sickle cell disease (SCD) treatment. While v...
12/3/2018 2:27 PM
Options traders are making a beeline toward Global Blood Therapeutics Inc (NASDAQ:GBT), after the Food and Drug Administration (FDA) agreed to the company's proposal for an accelerated approval pathw...
1/9/2018 2:58 PM
The U.S. stock market is scaling record highs once again, as bank stocks surge ahead of the start of earnings season. A rally in healthcare shares is also lifting the broader equities indexes, with s...
10/23/2017 9:17 AM
U.S. stocks are pacing for a positive open this morning, as the focus stays on corporate earnings. Among the stocks making moves this morning are toy company Hasbro, Inc. (NASDAQ:HAS), electric vehic...
3/8/2017 2:51 PM
Rising rate-hike jitters are weighing on stocks after this morning's jobs report. Among specific equities in focus are social media concern Snap Inc (NYSE:SNAP), biotech stock Global Blood Therapeuti...
PEOPLE ALSO SEARCH FOR

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center